"Breakthrough Drug Delays Menopause Indefinitely, Boosts Longevity"

Researchers at Oviva Therapeutics have developed an injection that could potentially delay or prevent the onset of menopause by increasing levels of the anti-Mullerian hormone (AMH), which plays a role in ovulation. The drug, currently being tested in rodents, could extend the time to menopause and potentially boost women's longevity. While the treatment shows promise, it may come with a high cost and potential risks, as hormone replacement therapy has been linked to increased health risks. This development comes amid a debate on whether menopause should be viewed as a condition to be treated or a natural part of aging.